ArticleInflammatory bowel diseases2022

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.

Rahul S Dalal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.